Medicine Name: Dificid
Dosage Form & Strength: Tablets: 200 mg and Oral Suspension: 200 mg/5 mL
Manufactured By: Merck
Dificid (fidaxomicin) is a macrolide antibacterial used in adult and pediatric patients aged 6 months and older for the treatment of C. difficile-associated diarrhea. This antibiotic medicine is not to be used for treating other types of infections in the body.
Adult Patients: The recommended dosage of Dificid for adult patients is one 200 mg tablet administered orally twice daily with or without food for 10 days.
Pediatric Patients (6 Months to Less than 18 Years of Age): The recommended dosage for pediatric patients weighing at least 12.5 kg and able to swallow tablets is one 200 mg tablet administered orally twice daily for 10 days. If not able to swallow tablets, pediatric patients may be dosed with Dificid oral suspension as:
- Pediatric patients weighing 4 kg to less than 7 kg: 2 mL administered orally twice daily
- Pediatric patients weighing 7 kg to less than 9 kg: 3 mL administered orally twice daily
- Pediatric patients weighing 9 kg to less than 12.5 kg: 4 mL administered orally twice daily
- Pediatric patients weighing 12.5 kg and above: 5 mL administered orally twice daily
All Trademarks and Brands that appear on the website belong to their respective owners and indianpharmanetwork does not lay any claim on them we only provide Information.